315 related articles for article (PubMed ID: 17206696)
1. Multicenter randomized-controlled clinical trial of probiotics (Lactobacillus johnsonii, LA1) on early endoscopic recurrence of Crohn's disease after lleo-caecal resection.
Van Gossum A; Dewit O; Louis E; de Hertogh G; Baert F; Fontaine F; DeVos M; Enslen M; Paintin M; Franchimont D
Inflamm Bowel Dis; 2007 Feb; 13(2):135-42. PubMed ID: 17206696
[TBL] [Abstract][Full Text] [Related]
2. Ineffectiveness of Lactobacillus johnsonii LA1 for prophylaxis of postoperative recurrence in Crohn's disease: a randomised, double blind, placebo controlled GETAID trial.
Marteau P; Lémann M; Seksik P; Laharie D; Colombel JF; Bouhnik Y; Cadiot G; Soulé JC; Bourreille A; Metman E; Lerebours E; Carbonnel F; Dupas JL; Veyrac M; Coffin B; Moreau J; Abitbol V; Blum-Sperisen S; Mary JY
Gut; 2006 Jun; 55(6):842-7. PubMed ID: 16377775
[TBL] [Abstract][Full Text] [Related]
3. The probiotic VSL#3 has anti-inflammatory effects and could reduce endoscopic recurrence after surgery for Crohn's disease.
Fedorak RN; Feagan BG; Hotte N; Leddin D; Dieleman LA; Petrunia DM; Enns R; Bitton A; Chiba N; Paré P; Rostom A; Marshall J; Depew W; Bernstein CN; Panaccione R; Aumais G; Steinhart AH; Cockeram A; Bailey RJ; Gionchetti P; Wong C; Madsen K
Clin Gastroenterol Hepatol; 2015 May; 13(5):928-35.e2. PubMed ID: 25460016
[TBL] [Abstract][Full Text] [Related]
4. Crohn's disease activity index does not correlate with endoscopic recurrence one year after ileocolonic resection.
Regueiro M; Kip KE; Schraut W; Baidoo L; Sepulveda AR; Pesci M; El-Hachem S; Harrison J; Binion D
Inflamm Bowel Dis; 2011 Jan; 17(1):118-26. PubMed ID: 20848538
[TBL] [Abstract][Full Text] [Related]
5. Low-dose budesonide treatment for prevention of postoperative recurrence of Crohn's disease: a multicentre randomized placebo-controlled trial. German Budesonide Study Group.
Ewe K; Böttger T; Buhr HJ; Ecker KW; Otto HF
Eur J Gastroenterol Hepatol; 1999 Mar; 11(3):277-82. PubMed ID: 10333200
[TBL] [Abstract][Full Text] [Related]
6. Infliximab Reduces Endoscopic, but Not Clinical, Recurrence of Crohn's Disease After Ileocolonic Resection.
Regueiro M; Feagan BG; Zou B; Johanns J; Blank MA; Chevrier M; Plevy S; Popp J; Cornillie FJ; Lukas M; Danese S; Gionchetti P; Hanauer SB; Reinisch W; Sandborn WJ; Sorrentino D; Rutgeerts P;
Gastroenterology; 2016 Jun; 150(7):1568-1578. PubMed ID: 26946343
[TBL] [Abstract][Full Text] [Related]
7. Saccharomyces boulardii does not prevent relapse of Crohn's disease.
Bourreille A; Cadiot G; Le Dreau G; Laharie D; Beaugerie L; Dupas JL; Marteau P; Rampal P; Moyse D; Saleh A; Le Guern ME; Galmiche JP;
Clin Gastroenterol Hepatol; 2013 Aug; 11(8):982-7. PubMed ID: 23466709
[TBL] [Abstract][Full Text] [Related]
8. Ineffectiveness of probiotics in preventing recurrence after curative resection for Crohn's disease: a randomised controlled trial with Lactobacillus GG.
Prantera C; Scribano ML; Falasco G; Andreoli A; Luzi C
Gut; 2002 Sep; 51(3):405-9. PubMed ID: 12171964
[TBL] [Abstract][Full Text] [Related]
9. Lactobacillus GG in inducing and maintaining remission of Crohn's disease.
Schultz M; Timmer A; Herfarth HH; Sartor RB; Vanderhoof JA; Rath HC
BMC Gastroenterol; 2004 Mar; 4():5. PubMed ID: 15113451
[TBL] [Abstract][Full Text] [Related]
10. Placebo-controlled clinical trial of mesalazine in the prevention of early endoscopic recurrences after resection for Crohn's disease. Groupe d'Etudes Thérapeutiques des Affections Inflammatoires Digestives (GETAID).
Florent C; Cortot A; Quandale P; Sahmound T; Modigliani R; Sarfaty E; Valleur P; Dupas JL; Daurat M; Faucheron JL; Lerebours E; Michot F; Belaiche J; Jacquet N; Soulé JC; Rothman N; Gendre JP; Malafosse M
Eur J Gastroenterol Hepatol; 1996 Mar; 8(3):229-33. PubMed ID: 8724022
[TBL] [Abstract][Full Text] [Related]
11. A randomized, double-blind trial of Lactobacillus GG versus placebo in addition to standard maintenance therapy for children with Crohn's disease.
Bousvaros A; Guandalini S; Baldassano RN; Botelho C; Evans J; Ferry GD; Goldin B; Hartigan L; Kugathasan S; Levy J; Murray KF; Oliva-Hemker M; Rosh JR; Tolia V; Zholudev A; Vanderhoof JA; Hibberd PL
Inflamm Bowel Dis; 2005 Sep; 11(9):833-9. PubMed ID: 16116318
[TBL] [Abstract][Full Text] [Related]
12. Crohn's disease management after intestinal resection: a randomised trial.
De Cruz P; Kamm MA; Hamilton AL; Ritchie KJ; Krejany EO; Gorelik A; Liew D; Prideaux L; Lawrance IC; Andrews JM; Bampton PA; Gibson PR; Sparrow M; Leong RW; Florin TH; Gearry RB; Radford-Smith G; Macrae FA; Debinski H; Selby W; Kronborg I; Johnston MJ; Woods R; Elliott PR; Bell SJ; Brown SJ; Connell WR; Desmond PV
Lancet; 2015 Apr; 385(9976):1406-17. PubMed ID: 25542620
[TBL] [Abstract][Full Text] [Related]
13. High dose probiotic and prebiotic cotherapy for remission induction of active Crohn's disease.
Fujimori S; Tatsuguchi A; Gudis K; Kishida T; Mitsui K; Ehara A; Kobayashi T; Sekita Y; Seo T; Sakamoto C
J Gastroenterol Hepatol; 2007 Aug; 22(8):1199-204. PubMed ID: 17688660
[TBL] [Abstract][Full Text] [Related]
14. A randomized double-blind trial on perioperative administration of probiotics in colorectal cancer patients.
Gianotti L; Morelli L; Galbiati F; Rocchetti S; Coppola S; Beneduce A; Gilardini C; Zonenschain D; Nespoli A; Braga M
World J Gastroenterol; 2010 Jan; 16(2):167-75. PubMed ID: 20066735
[TBL] [Abstract][Full Text] [Related]
15. Direct retrospective comparison of adalimumab and infliximab in preventing early postoperative endoscopic recurrence after ileocaecal resection for crohn's disease: results from the MULTIPER database.
Kotze PG; Yamamoto T; Danese S; Suzuki Y; Teixeira FV; de Albuquerque IC; Saad-Hossne R; de Barcelos IF; da Silva RN; da Silva Kotze LM; Olandoski M; Sacchi M; Yamada A; Takeuchi K; Spinelli A
J Crohns Colitis; 2015 Jul; 9(7):541-7. PubMed ID: 25820017
[TBL] [Abstract][Full Text] [Related]
16. Treatment of relapsing mild-to-moderate ulcerative colitis with the probiotic VSL#3 as adjunctive to a standard pharmaceutical treatment: a double-blind, randomized, placebo-controlled study.
Tursi A; Brandimarte G; Papa A; Giglio A; Elisei W; Giorgetti GM; Forti G; Morini S; Hassan C; Pistoia MA; Modeo ME; Rodino' S; D'Amico T; Sebkova L; Sacca' N; Di Giulio E; Luzza F; Imeneo M; Larussa T; Di Rosa S; Annese V; Danese S; Gasbarrini A
Am J Gastroenterol; 2010 Oct; 105(10):2218-27. PubMed ID: 20517305
[TBL] [Abstract][Full Text] [Related]
17. Fecal calprotectin one year after ileocaecal resection for Crohn's disease--a comparison with findings at ileocolonoscopy.
Lasson A; Strid H; Ohman L; Isaksson S; Olsson M; Rydström B; Ung KA; Stotzer PO
J Crohns Colitis; 2014 Aug; 8(8):789-95. PubMed ID: 24418661
[TBL] [Abstract][Full Text] [Related]
18. Male gender, active smoking and previous intestinal resection are risk factors for post-operative endoscopic recurrence in Crohn's disease: results from a prospective cohort study.
Auzolle C; Nancey S; Tran-Minh ML; Buisson A; Pariente B; Stefanescu C; Fumery M; Marteau P; Treton X; Hammoudi N; ; Jouven X; Seksik P; Allez M
Aliment Pharmacol Ther; 2018 Nov; 48(9):924-932. PubMed ID: 30126030
[TBL] [Abstract][Full Text] [Related]
19. Improvement of the human intestinal flora by ingestion of the probiotic strain Lactobacillus johnsonii La1.
Yamano T; Iino H; Takada M; Blum S; Rochat F; Fukushima Y
Br J Nutr; 2006 Feb; 95(2):303-12. PubMed ID: 16469146
[TBL] [Abstract][Full Text] [Related]
20. Modulation of Helicobacter pylori colonization with cranberry juice and Lactobacillus johnsonii La1 in children.
Gotteland M; Andrews M; Toledo M; Muñoz L; Caceres P; Anziani A; Wittig E; Speisky H; Salazar G
Nutrition; 2008 May; 24(5):421-6. PubMed ID: 18343637
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
